With plans to raise nearly $1.3 billion, Philippine fintech unicorn Mynt has secured regulatory approval for what is set to become the nation’s largest initial public offering. The firm, which powers the ubiquitous GCash platform, aims to finalize its market debut by October 20 despite lingering volatility in global financial markets.
Artificial intelligence is increasingly building its own successor. Anthropic revealed that its Claude assistant now steers 26% of the company's research and development work, a sharp climb from near-zero levels just one year ago, as the lab attempts to provide greater transparency into the rapid evolution of its internal systems.
Asian equities climbed on Friday as a retreat in global oil prices calmed investor anxiety over inflation, while signals from the Federal Reserve and a historic shift from the Bank of Japan provided a clearer picture for regional markets navigating a changing interest-rate landscape.
Net profit at Ichimasa Kamaboko Co. Ltd. dropped to 326 million yen for the fiscal year ending June 30, a sharp decline from the 746 million yen reported the previous year. The Japanese seafood processor saw earnings per share fall to 17.81 yen, down from 40.67 yen during the prior period.
Swedish buyout group EQT AB has finalized a $1.2 billion deal to acquire a massive logistics portfolio from Rexford Industrial Realty. The transaction signals a strategic expansion for EQT into Southern California, targeting supply-constrained industrial markets that rely heavily on the region’s critical port infrastructure.
Tony Fernandes, co-founder and adviser of AirAsia, dismissed speculation that the airline is seeking state intervention or facing asset seizures. The executive’s comments followed a sharp 21% drop in the company’s share price on Thursday, triggered by reports that the Malaysian government was exploring potential contingency plans for the carrier's domestic market share.
TotalEnergies has finalized a strategic partnership with Global Infrastructure Partners, a unit of BlackRock, to monetize a portion of its African midstream assets. The deal provides the French energy giant with a $1.8 billion capital injection, in exchange for long-term throughput tariffs spanning up to 15 years.
Advance Create Co. Ltd. trimmed its net loss to 768 million yen for the nine months ended June 30, a significant improvement over the 1.41 billion yen deficit recorded during the same period last year. The Japanese firm’s latest financial disclosures reveal a gradual recovery in profitability despite stagnant top-line growth.
Asian equity markets climbed Friday while bond yields retreated, fueled by a cooling in global oil prices and growing confidence in central bank efforts to contain inflation. Investors are now shifting their focus toward the Bank of Japan, anticipating a key policy decision on interest rates later today.
Cosel Co. Ltd. posted a net profit of 661 million yen for the first quarter ending August 20, a sharp recovery from the 68 million yen loss reported during the same period last year. The Japanese manufacturer’s financial turnaround reflects significant growth in revenue alongside a return to positive operating margins.
Shares of Cooper Cos. climbed 3% to $55.27 in after-hours trading Thursday following reports that activist investor Jana Partners is demanding a leadership overhaul. The firm is pressuring the contact-lens manufacturer to replace its chief executive and explore a potential sale of its core business to reverse persistent underperformance.
A cloud of uncertainty is hanging over the communications sector as investors retreat from consumer-facing giants, unnerved by shifting market sentiment and impending regulatory hurdles. Shares in Comcast and Netflix faced sharp sell-offs today, signaling a broader loss of confidence in the stability of high-growth media and internet providers.
A retreat in Treasury yields provided a reprieve for the utilities sector, lifting shares of power producers after a prolonged period of downward pressure. The sector, which had struggled throughout the year during a sharp spike in bond yields, is showing signs of stabilizing as market interest rates pull back.
A 26% plunge for Xenon Pharmaceuticals highlights the volatility of clinical development, as the company halts enrollment for its depression drug azetukalner. While investors retreated from the biotech firm, the market rewarded Ultragenyx Pharmaceutical for a rare disease milestone and signaled confidence in the capital allocation strategy of BRT Apartments.
Ingredion shareholders are set for a modest payout boost, as the board confirmed a quarterly cash dividend increase to 83 cents per share. This adjustment from the previous 82-cent rate continues a long-standing pattern of third-quarter hikes for the food ingredient manufacturer, marking twelve consecutive years of growth.
Michael Murray has stepped into the dual role of chief executive and chief financial officer at Sadot Group, replacing Chagay Ravid. The transition, confirmed in a Thursday filing with the Securities and Exchange Commission, marks a significant shift in the company’s leadership structure as it navigates its next phase of operations.
With crude futures settling at $101.91 a barrel, U.S. equities clawed back recent losses as investors bet on the Federal Reserve’s strategy to tame inflation. The market shift followed signs of cooling energy costs and a cooling in Treasury yields, providing a reprieve from the volatility that defined the previous week.
The board of directors at BRT Apartments Corp. has greenlit a fresh $10 million allocation for the company's share-repurchase program. This move effectively replenishes the real estate investment trust's capital reserve earmarked for buying back its own stock as it navigates the current market cycle.
Shares of Xenon Pharmaceuticals plunged 20% to $45.98 in after-hours trading Thursday after the company halted new enrollment for trials testing azetukalner. The decision follows a series of adverse events in studies targeting depression and bipolar disorder, prompting an immediate review by the firm's data safety monitoring board.
Phoenix Education Partners has reached an agreement to acquire Fuel50, an artificial intelligence platform specialized in workforce transformation. The acquisition aligns with the parent company of the University of Phoenix’s broader mission to integrate skills-focused educational tools for working professionals and corporate partners navigating shifting labor market demands.
Oil futures retreated to $101.91 a barrel, easing investor anxiety over energy-driven inflation and sparking a broad rally across U.S. markets. With crude prices contained and confidence in Federal Reserve Chairman Kevin Warsh’s policy strategy growing, major indices clawed back recent losses during Thursday’s trading session.
The Food and Drug Administration has cleared Fayuvi as the first treatment for Sanfilippo syndrome type A, a rare genetic disorder that progressively damages the brain and nervous system. This landmark decision marks a shift from merely managing symptoms to addressing the underlying course of the debilitating inherited disease.
Nearly two decades after its exit, ExxonMobil is closing in on a preliminary deal to resume oil field investments in Venezuela. The move arrives as energy markets struggle to price in the escalating conflict in Iran, with major investors seeking stability in South American reserves to hedge against geopolitical uncertainty.
The Food and Drug Administration has granted approval to Fayuvi, the first treatment specifically designed to address the underlying progression of Sanfilippo syndrome type A. Following the announcement, shares of Ultragenyx Pharmaceutical rose 13% to close at $14.50, signaling a potential recovery for the company after a volatile year.
A retreat in oil prices and Treasury yields has reignited investor appetite for raw materials, pushing metal and grain producers higher across the board. The cooling of broader economic pressures provided the necessary relief to alleviate long-standing demand concerns that previously weighed on the sector's performance throughout the trading session.
Fifty years of uninterrupted payout increases have earned McDonald’s a rare seat among the elite "Dividend Kings." The fast-food giant announced a 3.8% bump to its quarterly dividend this week, signaling a long-term commitment to shareholder returns that has persisted through five decades of shifting consumer habits and market volatility.
Industrial and transportation stocks held steady today as manufacturing output concerns weighed on investor sentiment. Boeing shares deepened their slide following critical updates regarding 737 MAX production rates, while broader industrial performance remained muted against a backdrop of shifting labor demands and strategic pivots across the global automotive and defense landscape.
A surge in drug development optimism propelled health care stocks higher, led by a pivotal FDA approval for Ultragenyx. The rare disease specialist saw its shares rally after regulators cleared its gene therapy for a pediatric neurodevelopmental disorder, signaling a significant breakthrough for the company’s specialized treatment pipeline.
Consumer sector equities climbed on Tuesday as Federal Reserve interest rate policy began to soothe investor anxiety regarding runaway inflation. The broader market sentiment shifted toward stability, allowing retail and lifestyle brands to recover ground lost during recent sessions of economic volatility across domestic markets.
Modine shareholders will see the formal separation of its performance technologies unit on September 28, triggering a complex merger with Gentherm that involves the issuance of 2.9 million new shares and a recalibrated dividend structure to preserve the tax-free status of the transaction.
